FGF19 and diabetes mellitus: The administration of recombinant human FGF19 or FGF19 overexpression in leptin deficient diabetic mice was shown to reduce weight gain, reverse diabetes, increase lipid oxidation rate decreasing also hepatic triacylglycerol content (Fu et al., 2004).